Piper Sandler Downgrades Inozyme Pharma Inc. (INZY) to Neutral

May 19, 2025 3:38 AM EDT Send to a Friend
Piper Sandler analyst Allison M. Bratzel downgraded Inozyme Pharma Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login